More than
2000
patients
till date across India have been treated with Cizumab for various indications
India's First Biosimilar of Bevacizumab approved by DGCI was launched in the year 2016 by Hetero. Cizumab is a complex protein structure manufactured using multiple state-of-the-art-methods, which is used for managing multiple solid tumors. Unlike most other cancer drugs available in the market which are chemical based Cizumab is a Biosimilar
Bevacizumab, a monoclonal antibody (MAB) is made from living cells.
They are structurally large and complex molecules and are carefully monitored during development for consistent quality.
Cizumab is an anti-angiogenic drug. That is, it prevents the formation of new blood vessels. It blocks a protein called vascular endothelial growth factor, or VEGF which is involved in angiogenesis. Normal cells also make VEGF, but cancer cells make excess VEGF at the site of the tumour. This for an increased blood supply to help the tumour grow. By blocking VEGF Cizumab prevents the growth of new blood vessels that feed tumors. Due to this the tumour will starve and ill not be able to grow.
Unlike chemotherapy that attacks the cancer cells, the purpose of Cizumab is to block the blood supply that feeds the tumor which will prevent the tumour grow.
Colorectal cancer may also called bowel cancer, colon cancer, or rectal cancer. Cizumab injection is used to treat colorectal cancer.
Glioblastoma, also known as glioblastoma multiforme (GBM). GBM is a type of brain cancer. Cizumab Injection is a anti-angiogenic medication used to treat brain tumors.
NSCLC is a most common type of Lung Cancer. Cizumab is used in the treatment of lung cancer.
Metastatic Renal Cell Carcinoma is the most common type of kidney cancer. Cizumab Injection is used to treat Renal Cell Carcinoma.
Cizumab injection is used to treat breast cancers.
Cervical cancer is a type of cancer that starts in the cells of cervix. Cizumab is used to treat Cervical Carcinoma.
Bevacizumab has an advantage of showing significantly improved results in various types of cancers, but being an expensive therapy, cost has always been a major hurdle for patients. Cizmab a biosimilar of Bevacizumab is a boon to many patients as it is able to show similar efficacy like Bevacizumab in various indications, and comes at a much affordable price. Cizumab is available in two strengths Cizumab 100 and Cizumab 400.
Result is very effective. Both my parents suffering from colorectal cancer. Cizumab has helped me to sort this issue. I have seen significant improvement. They says it has helped them a lot. Overall, I am happy with this product. Thank you!
Result is quite good. I was suffering with kidney cancer from two years. This medicine is helpful for me in treating cancer.
It's a good anticancer drug at affordable price. Product is very good and effective. I recommend Cizumab in treating cancer.
I have taken many tablets for cancer. But not found any result. One of my family doctor suggested this drug. Today I thank to Cizumab for giving good result in short time.
Available At Near by Pharmacy Stores - ALL OVER INDIA
lead@heterohealthcare.com
FILL THE FORM FOR ANY KIND OF ORDER / TRADE ENQUIRY
Copyright © All Rights Reserved by Hetero Healthcare Limited.